PureTech Health PLC
Total Valuation
EURAs of June 30, 2026, PureTech Health PLC carries a market capitalization of 335.80M, placing it among publicly traded companies globally. Its enterprise value stands at 152.17M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 335.80M |
| Enterprise Value | 152.17M |
Important Dates
PureTech Health PLC's next confirmed earnings release is scheduled for April 29, 2027.
| Earnings Date | 4/29/2027 |
Share Statistics
As of June 30, 2026, PureTech Health PLC has 242.62M shares outstanding.
| Shares Outstanding | 242.62M |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | 0.99 |
| P/TBV Ratio | 0.99 |
Financial Position
As of June 30, 2026, PureTech Health PLC maintains a current ratio of 4.60, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.60 |
| Quick Ratio | 4.03 |
| Debt / Equity | 4.82 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 66.00 |
Stock Price Statistics
EURThese figures are as of the close on August 27, 2026.
| 50-Day Moving Average | 1.45 |
Balance Sheet
EURAs of June 30, 2026, PureTech Health PLC holds 193.76M in cash and equivalents against 16.02M in total debt, resulting in a net debt position of -101.45M. Total book value stands at 338.07M, with working capital of 172.84M providing operational flexibility.
| Cash & Cash Equivalents | 193.76M |
| Total Debt | 16.02M |
| Net Debt | -101.45M |
| Equity (Book Value) | 338.07M |
| Book Value Per Share | 1.39 |
| Working Capital | 172.84M |